Caffeic acid improves memory impairment and brain glucose metabolism via ameliorating cerebral insulin and leptin signaling pathways in high-fat diet-induced hyperinsulinemic rats

Food Research International

Volumn 77, Issue , 2015, Pages 24-33

  Chang, Wen Chang ^a   Kuo, Po Ling ^b   Chen, Chen Wen ^a   Wu, James Swi Bea ^a   Shen, Szu Chuan ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

Caffeic acid; Cerebral carbohydrate metabolism; Dementia; Hyperinsulinemia; Memory decline

Indexed keywords

BRAIN; CARBOHYDRATES; ELECTROPHORESIS; ENZYMES; GLUCOSE; HORMONES; METABOLISM; NEURODEGENERATIVE DISEASES; NUTRITION; ORGANIC ACIDS; PHYSIOLOGY; PROTEINS; RATS;

CAFFEIC ACIDS; CARBOHYDRATE METABOLISM; COGNITIVE PERFORMANCE; DEMENTIA; HYPERINSULINEMIA; INSULIN-DEGRADING ENZYMES; PASSIVE AVOIDANCE TESTS; WESTERN-BLOT ANALYSIS;

INSULIN;

EID: 84943661003     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2015.04.010     Document Type: Article

References (74)

1. Adisakwattana S., Roengsamarn S., Hsu W.H., Yibchok-anun S. Mechanisms of antihyperglycemic effect of p-methoxycinnamic acid in normal and streptozotocin-induced diabetic rats. Life Science 2005, 78(4):406-412.
2. Anwar J., Spanevello R.M., Thome G., Stefanello N., Schmatz R., Gutierres J., et al. Effects of caffeic acid on behavioral parameters and on the activity of acetylcholinesterase in different tissues from adult rats. Pharmacology Biochemistry and Behavior 2012, 103(2):386-394.
3. Avram M.M., Avram A.S., James W.D. Subcutaneous fat in normal and diseased states: 1. Introduction. Journal of the American Academy of Dermatology 2005, 53(4):663-670.
4. Bahorun T., Luximon-Ramma A., Crozier A., Aruoma O.I. Total phenol, flavonoid, proanthocyanidin and vitamin C levels and antioxidant activities of Mauritian vegetables. Journal of the Science of Food and Agriculture 2004, 84(12):1553-1561.
5. Battu C.E., Rieger D., Loureiro S., Furtado G.V., Bock H., Saraiva-Pereira M.L., et al. Alterations of PI3K and Akt signaling pathways in the hippocampus and hypothalamus of Wistar rats treated with highly palatable food. Nutritional Neuroscience 2012, 15(1):10-17.
6. Björk B.F., Katzov H., Kehoe P., Fratiglioni L., Winblad B., Prince J.A., et al. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE. Neurobiology of Aging 2007, 28(9):1374-1380.
7. Buettner R., Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Scholmerich J., et al. Defining high-fat-diet rat models: Metabolic and molecular effect of different fat types. Journal of Molecular Endocrinology 2006, 36:485-501.
8. Buettner R., Scholmerich J., Bollheimer L.C. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity 2007, 15(4):798-808.
9. Chang W.C., Shen S.C., Wu J.S.B. Protective effects of vescalagin from pink wax apple [Syzygium samarangense (Blume) Merrill and Perry] fruit against methylglyoxal-induced inflammation and carbohydrate metabolic disorder in rats. Journal of Agricultural and Food Chemistry 2013, 61(29):7102-7109.
10. Chao L., Marcus-Samuels B., Mason M.M., Moitra J., Vinson C., Arioglu E., et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. The Journal of Clinical Investigation 2000, 106(10):1221-1228.
11. Chao C.Y., Mong M.C., Chan K.C., Yin M.C. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Molecular Nutrition & Food Research 2010, 54(3):388-395.
12. de Ferranti S., Mozaffarian D. The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences. Clinical Chemistry 2008, 54(6):945-955.
13. de la Monte S.M., Longato L., Tong M., Wands J.R. Insulin resistance and neurodegeneration: Roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. Current Opinion in Investigational Drugs 2009, 10(10):1049-1060.
14. de la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system relevance to AD. Journal of Alzheimer's Disease 2005, 7(1):45-61.
15. Duan C., Li M., Rui L. SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. The Journal of Biological Chemistry 2004, 279(42):43684-43691.
16. Farrell T.L., Ellam S.L., Forrelli T., Williamson G. Attenuation of glucose transport across Caco-2 cell monolayers by a polyphenol-rich herbal extract: Interactions with SGLT1 and GLUT2 transporters. BioFactors 2013, 39(4):448-456.
17. Fawcett J., Duckworth W.C. Hyperglycaemia and hyperinsulinaemia: Is insulin-degrading enzyme the missing link?. Diabetologia 2009, 52(8):1457-1460.
18. Frederich R.C., Hamann A., Anderson S., Löllmann B., Lowell B.B., Flier J.S. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Medicine 1995, 1(12):1311-1314.
19. Gasparini L., Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends in Neurosciences 2003, 26(8):404-406.
20. Greco S.J., Sarkar S., Johnston J.M., Tezapsidis N. Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochemical and Biophysical Research Communications 2009, 380(1):98-104.
21. Greenwood C.E., Winocur G. High-fat diets, insulin resistance and declining cognitive function. Neurobiology of Aging 2005, 26(1):42-45. (Suppl. 1).
22. Gupta A., Bisht B., Dey C.S. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology 2011, 60(6):910-920.
23. Hallakou S., Doare L., Foufelle F., Kergoat M., Guerre-Millo M., Berthault M.F., et al. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 1997, 46(9):1393-1399.
24. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
25. Huang D.W., Shen S.C., Wu J.S.B. Effects of caffeic acid and cinnamic acid on glucose uptake in insulin-resistant mouse hepatocytes. Journal of Agricultural and Food Chemistry 2009, 57(17):7687-7692.
26. Jensen M.D., Haymond M.W., Rizza R.A., Cryer P.E., Miles J.M. Influence of body fat distribution on free fatty acid metabolism in obesity. Journal of Clinical Investigation 1989, 83(4):1168-1173.
27. Jeon B.T., Jeong E.A., Shin H.J., Lee Y., Lee D.H., Kim H.J., et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012, 61(6):1444-1454.
28. Jolivalt C.G., Lee C.A., Beiswenger K.K., Smith J.L., Orlov M., Torrance M.A., et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin. Journal of Neuroscience Research 2008, 86(15):3265-3274.
29. Jung U.J., Lee M.K., Park Y.B., Jeon S.M., Choi M.S. Antihyperglycemic and antioxidant properties of caffeic acid I db/db mice. The Journal of Pharmacology and Experimental Therapeutics 2006, 318(2):476-483.
30. Kalmijn S., van Boxtel M.P.J., Ocké M., Verschuren W.M.M., Kromhout D., Launer L.J. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004, 62(2):275-280.
31. Karamohamed S., Demissie S., Volcjak J., Liu C., Heard-Costa N., Liu J., et al. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 2003, 52(6):1562-1567.
32. Kelley G.L., Allan G., Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004, 145(2):548-555.
33. Kosari S., Badoer E., Nguyen J.C., Killcross A.S., Jenkins T.A. Effect of western and high fat diets on memory and cholinergic measures in the rat. Behavioural Brain Research 2012, 235(1):98-103.
34. Laffel L. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes/Metabolism Research and Reviews 1999, 15(6):412-426.
35. Latha R.C.R., Daisy P. Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Tewminalia bellerica Roxb. in streptozotocin-induced diabetic rats. Chemico-Biological Interactions 2011, 189(1-2):112-118.
36. Lee B.H., Hsu W.H., Huang T., Chang Y.Y., Hsu Y.W., Pan T.M. Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated Wistar rats. Journal of Agricultural and Food Chemistry 2013, 61(6):1288-1298.
37. Lee B.H., Hsu W.H., Pan T.M. Inhibitory effects of Dioscorea polysaccharide on TNF-induced insulin resistance in FL83B cells. Journal of Agricultural and Food Chemistry 2011, 59(10):5279-5285.
38. Lester-Coll N., Rivera E.J., Soscia S.J., Doiron K., Wands J.R., de la Monte S.M. Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. Journal of Alzheimer's Disease 2006, 9(1):13-33.
39. Li L., Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: A review. Brain Research Reviews 2007, 56(2):384-402.
40. Lichtenstein A.H., Schwab U.S. Relationship of dietary fat to glucose metabolism. Atherosclerosis 2000, 150(2):227-243.
41. Longato L., Tong M., Wands J.R., de la Monte S.M. High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism. Hepatology Research 2012, 42(4):412-427.
42. Luximon-Ramma A., Bahorun T., Crozier A. Antioxidant actions and phenolic and vitamin C contents of common Mauritian exotic fruits. Journal of the Science of Food and Agriculture 2003, 83(5):496-502.
43. Marks J.L., Porte D., Stahl W.L., Baskin D.G. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 1990, 127(6):3234-3236.
44. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diavetologia 1985, 28(7):412-419.
45. McNeilly A.D., Williamson R., Balfour D.J., Stewart C.A., Sutherland C. A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia 2012, 55(11):3061-3070.
46. McNeilly A.D., Williamson R., Sutherland C., Balfour D.J., Stewart C.A. High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behavioural Brain Research 2011, 217(1):134-141.
47. Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. American Journal of Physiology - Endocrinology and Metabolism 2009, 297(6):E1247-E1259.
48. Mullen E., Ohlendieck K. Proteomic analysis of the mitochondria-enriched fraction from diabetic rat skeletal muscle. Journal of Integrated Omics 2011, 1(1):108-114.
49. Oboh G., Agunloye O., Akinyemi A., Ademiluyi A., Adefegha S. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brain-in vitro. Neurochemical Research 2013, 38(2):413-419.
50. Okabayashi Y., Maddux B.A., Mcdonald A.R., Logsdon C.D., Williams J.A., Goldfine I.D. Mechanisms of insulin-induced insulin-receptor downregulation: Decrease of receptor biosynthesis and mRNA levels. Diabetes 1989, 38(2):182-187.
51. Petersen K.F., Shulman G.I. Etiology of insulin resistance. The American Journal of Medicine 2006, 119(5, Supplement 1):S10-S16.
52. Pipatpiboon N., Pintana H., Pratchayasakul W., Chattipakorn N., Chattipakorn S.C. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. European Journal of Neuroscience 2013, 37(5):839-849.
53. Pivovarova O., Gögebakan Ö., Pfeiffer A.F.H., Rudovich N. Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells. Diabetologia 2009, 52(8):1656-1664.
54. Pratchayasakul W., Kerdphoo S., Petsophonsakul P., Pongchaidecha A., Chattipakorn N., Chattipakorn S.C. Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Science 2011, 88(13-14):619-627.
55. Qatanani M., Lazar M.A. Mechanisms of obesity-associated insulin resistance: Many choices on the menu. Genes & Development 2007, 21(12):1443-1455.
56. Rabe K., Lehrke M., Parhofer K.G., Broedl U.C. Adipokines and insulin resistance. Molecular Medicine 2008, 14(11-12):741-751.
57. Rothwell N., Stock M. The development of obesity in animals-The role of dietary factors. Clinics in Endocrinology and Metabolism 1984, 13(3):437-449.
58. Saltiel A.R., Pessin J.E. Insulin signaling pathways in time and space. Trends in Cell Biology 2002, 12(2):65-71.
59. Samuel V.T. Fructose induced lipogenesis: From sugar to fat to insulin resistance. Trends in Endocrinology and Metabolism 2011, 22(2):60-65.
60. Scalbert A., Johnson I.T., Saltmarsh M. Polyphenols: Antioxidants and beyond. The American Journal of Clinical Nutrition 2005, 81(1):215S-217S.
61. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., Heyman R.A., Briggs M., Deeb S., et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. The EMBO Journal 1996, 15(19):5336-5348.
62. Searcy J.L., Phelps J.T., Pancani T., Kadish I., Popovic J., Anderson K.L., et al. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease. Journal of Alzheimer's Disease 2012, 30(4):943-961.
63. Shahidi S., Komaki A., Mahmoodi M., Atrvash N., Ghodrati M. Ascorbic acid supplementation could affect passive avoidance learning and memory in rat. Brain Research Bulletin 2008, 76(1-2):109-113.
64. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 2007, 100(3):328-341.
65. Tsuda S., Egawa T., Ma X., Oshima R., Kurogi E., Hayashi T. Coffee polyphenol caffeic acid but not chlorogenic acid increases 5'AMP-activated protein kinase and insulin-independent glucose transport in rat skeletal muscle. The Journal of Nutritional Biochemistry 2012, 23(11):1403-1409.
66. Warwick Z.S., Schiffman S.S. Role of dietary fat in calorie intake and weight gain. Neuroscience and Biobehavioral Reviews 1992, 16(4):585-596.
67. Watson G.S., Craft S. Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer's disease. European Journal of Pharmacology 2004, 490(1-3):97-113.
68. WHO http://www.who.int/diabetes/en/index.html.
69. Willis L.M., Shukitt-Hale B., Joseph J.A. Recent advances in berry supplementation and age-related cognitive decline. Current Opinion in Clinical Nutrition and Metabolic Care 2009, 12(1):91-94.
70. Winocur G., Greenwood C.E. The effects of high fat diets and environmental influences on cognitive performance in rats. Behavioural Brain Research 1999, 101(2):153-161.
71. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003, 112(12):1821-1830.
72. Yoshida H., Kohno Y., Endo H., Hasegawa M., Yamaguchi J., Tomisawa K., et al. Identification of metabolites of KE-298, a new antirheumatic drug, and its physiological properties in rats. Biological & Pharmaceutical Bulletin 1996, 19(3):424-429.
73. Zechner R., Strauss J.G., Haemmerle G., Lass A., Zimmermann R. Lipolysis: Pathway under construction. Current Opinion in Lipidology 2005, 16(3):333-340.
74. Zhao W.Q., Alkon D.L. Role of insulin and insulin receptor in learning and memory. Molecular and Cellular Endocrinology 2001, 177(1-2):125-134.